MIRA INFORM REPORT

 

 

Report Date :

25.02.2011

 

IDENTIFICATION DETAILS

 

Name :

ALPHA CHEM ADVANCED PHARMACEUTICAL INDUSTRY SAE

 

 

Registered Office :

92 El Hegaz Street, Heliopolis, Cairo

 

 

Country :

Egypt

 

 

Year of Establishment :

1995

 

 

Legal Form :

Egyptian Joint Stock Company

 

 

Line of Business :

Manufacture and export of human pharmaceuticals

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 1,000,000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

Egypt

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

SUMMARY

 

Company Name                                     : ALPHA CHEM ADVANCED PHARMACEUTICAL INDUSTRY SAE

Country of Origin                                    : Egypt

Legal Form                                            : Egyptian Joint Stock Company

Registration Date                                   : 1995

Issued Capital                                        : £E 27,500,000

Paid up Capital                                      : £E 27,500,000

Total Workforce                                     : 350

Activities                                               : Manufacture and export of human pharmaceuticals.

Financial Condition                                 : Undetermined

Payments                                             : Nothing detrimental uncovered

Recommended Credit Limit                     : US$ 1,000,000

 

COMPANY NAME

 

ALPHA CHEM ADVANCED PHARMACEUTICAL INDUSTRY SAE

 

 

company ADDRESS

 

Registered & Physical Address

Street               : 92 El Hegaz Street

Area                 : Heliopolis

Town                 : Cairo

Country             : Egypt

Telephone         : (20-2) 22410940 / 22419612

Facsimile          : (20-2) 26343987

 

Premises

Subject operates from a large suite of offices that are rented and located in the Central Business Area of Cairo.

 

Branch Office (s)

 

     Location                                                                                          Description

 

·       3rd Industrial Zone, 1st Desert Road                                                    Owned factory premises

     Badr City

     Cairo

     Tel: (20-2) 28640012 / 28640013 / 28640014

     Fax: (20-2) 28640003

 

 

KEY PRINCIPALS

 

     Name                                                                                              Position

 

·       Dr George Thabet Bassily                                                                  Chairman

 

·       Dr Samir Ernest Sadek                                                                      Vice Chairman

 

·       Dr Ezzat Halim Boutros                                                                     Director

 

·       Ehab Sobhi                                                                                       Sales Manager

 

·       Dr George Abd El Shahid                                                                   Factory Manager

 

·       Dr Emeil Tadrous                                                                              Marketing Manager

 

·       Ayman Adeeb                                                                                   Purchasing Manager

 

·       Salwa Helmy                                                                                    IT Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 1995

 

Legal Form                  : Egyptian Joint Stock Company

 

Issued Capital              : £E 27,500,000

 

Paid up Capital            : £E 27,500,000

 

Name of Shareholder (s)                                               Percentage

 

·       Dr George Thabet Bassily                                               83%

 

·       Dr Ezzat Halim Boutros                                                    9%

 

·       Alfa Chem for Pharmaceutical                                           8%

 

 

OPERATIONS

 

Activities: Engaged in the manufacture and export of human pharmaceuticals.

 

                 Subject is ISO 9001 and 14001 accredited.

 

Import Countries: India and Japan

 

Agencies Held:

 

·       Erhard Wagner

·       Geislich Wolhusen

·       Vinal

 

Export Countries: Yemen, Morocco and Sudan

 

Subject has a workforce of approximately 350 employees.

 

 

FINANCIAL DATA

 

Companies registered in Egypt are not legally required to make their accounts public and no financial information was released by the company or submitted by outside sources.

 

 

BANKERS

 

·       National Bank of Egypt

24 Sherif Street

     Cairo

     Tel: (20-2) 33924175

     Fax: (20-2) 33924143

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk and the above credit figure is within subject’s financial means.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.45.37

UK Pound

1

Rs.73.54

Euro

1

Rs.62.39

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.